Meanwhile, excessive STING and inflammasome activation have been identified as contributing to the progression of autoinflammatory diseases such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), acute myeloid leukemia (AML), sepsis and dry syndrome [83, 195, 198–202]. Here, STING1 is linked to systemic lupus erythematosus.